)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Stryker
Stryker (SYK) investor relations material
Stryker Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary29 Jan, 2026
Executive summary
Achieved outstanding Q4 and full-year 2025 results, with organic sales growth of 11% for Q4 and 10.3% for the year, surpassing $25 billion in sales.
Double-digit organic sales growth across Neurocranial, Endoscopy, Instruments, and Trauma and Extremities businesses globally.
U.S. organic sales growth was 11.2%, and international organic sales growth was 7.5%, led by emerging markets, South Korea, and Japan.
Adjusted operating income margin expanded by 100 bps to 30.2% in Q4 and 26.3% for the year, marking a second consecutive year of at least 100 basis points of adjusted operating margin expansion.
Strategic initiatives included new business units, active M&A, and specialized sales force splits, fueling growth and innovation.
Financial highlights
Q4 organic sales growth of 11% compared to 10.2% in Q4 2024; full-year organic sales growth of 10.3%.
Adjusted EPS for Q4 was $4.47, up 11.5% year-over-year; full-year adjusted EPS was $13.63, up 11.8%.
Adjusted gross margin for Q4 was 65.2%, 10 basis points lower year-over-year due to tariffs, offset by business mix and cost improvements.
Adjusted operating margin reached 30.2% of sales, 100 basis points higher than Q4 2024.
Year-to-date cash from operations was $5 billion, up $802 million from 2024, with free cash flow at 81% of adjusted net earnings.
Outlook and guidance
2026 organic net sales growth expected in the range of 8%-9.5%.
Adjusted net earnings per share guidance for 2026 is $14.90-$15.10.
Modestly positive price impact and slightly favorable foreign exchange expected in 2026.
Full-year tariff impacts for 2026 projected at $400 million, with $200 million incremental over 2025.
Reason for Spinal Implants' significant sales decline
Largest non-GAAP adjustments impacting reported EPS
Details on 2025 acquisition cash outflow
Mako penetration potential long-term?
How do sales force splits fuel MedSurg growth?
Strategy to absorb $400M tariffs in 2026?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Stryker earnings date
Q1 202630 Apr, 2026
Stryker
Next Stryker earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
A Pioneer in Medical Technologies
Stryker Corporation is an American medical technology company listed on the NYSE. Headquartered in Kalamazoo, Michigan, the company's operations extend across the globe, serving customers in over 100 countries. Stryker was founded in 1941 by Dr. Homer Stryker, an orthopedic surgeon from Michigan, the company has anchored its reputation on its range of medical devices. Stryker's products encompass a vast segment with everything from orthopedic implants to surgical instruments, and even hospital beds.
Building Upon Dr. Stryker’s Legacy
Dr. Homer Stryker's initial inventions, such as the mobile hospital bed and the turning frame, set the stage for the company's trajectory. Over the years, Stryker Corporation expanded its portfolio, venturing into various medical specialties, such as neurotechnology, spinal surgery, and endoscopy. Strategic acquisitions have played a crucial role in Stryker's growth and the company has absorbed various businesses within the industry, diversifying and expanding its portfolio. When looking at publicly traded peers to Stryker we find names like Medtronic and Abbott Laboratories as well as numerous divisions of massive international corporations such as GE.
Three Focus Areas
Stryker's products can be broadly categorized into three major sectors: Orthopedics, MedSurg, and Neurotechnology & Spine.
The Orthopedics division focuses on joint replacements, trauma and extremities, and other orthopedic surgeries. Products like hip and knee joint replacements and bone cement fall under this bracket.
MedSurg encompasses a wider spectrum. This category includes surgical equipment, navigation systems, patient-handling solutions, and emergency medical equipment. Noteworthy mentions include the power tools for precise bone surgeries and the 1588 AIM camera system for endoscopic surgeries.
The Neurotechnology & Spine department designs and manufactures equipment for the intricacies of neuro and spine surgeries. This division offers products like the Neuroform Atlas Stent System for brain aneurysm treatment and the LITe Decompression System for spine surgeries.
Dedicated Research and Development
Behind Stryker's extensive product portfolio lies its steadfast commitment to research and development. The company continually invests in R&D, ensuring its products not only meet but often exceed industry standards. This commitment to innovation is evident in the company's historically consistent rollout of advanced medical devices, many of which have been firsts in their respective fields.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage